Jayesh Beladiya, Dhruvi Mehta, Yashi Patel, Sandip Patel, Dharmistha Parmar, Sandip Dholakia, Devang Sheth, B Mahalakshmi, Chirag A Patel, Sai H S Boddu
Identifying and assessing salivary protein biomarkers for the noninvasive diagnosis of oral squamous cell carcinoma (OSCC) could significantly enhance early detection, guide timely intervention, and ultimately improve patient survival and quality of life. A comprehensive search of PubMed, Google Scholar, and EMBASE databases was conducted to identify studies that assessed the potential of salivary protein biomarkers for screening OSCC. To assess the validity of the studies, two reviewers independently extracted data on sensitivity, specificity, positive and negative likelihood ratios (PLR and NLR), and diagnostic odds ratios (DOR). Owing to the expected variation between studies, a random effects model was used to combine the extracted data. The meta-analysis included 28 studies including 3,507 patients with OSCC and 3,501 control subjects that evaluated 37 salivary protein biomarkers. Pooled analysis across all biomarkers revealed a sensitivity of 0.71 (95 % CI 0.690-0.720), specificity of 0.69 (95 % CI 0.68-0.71), PLR of 3.04 (95 % CI 2.56-3.60), NLR of 0.37 (95 % CI 0.33-0.43), and DOR of 11.7 (95 % CI 8.02-15.29). Further analysis compared five specific biomarkers: interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-8), matrix metalloproteinase-9 (MMP9), and cytokeratin 19 fragment 21-1 (CYFRA21-1). Notably, MMP9 and CYFRA21-1 demonstrated sensitivity of 1.00 and 0.81, respectively, with specificities of 0.58 and 0.91, respectively, and high area under the curve (AUC) values of 0.9932 and 0.9447, respectively. Despite promising results, heterogeneity across studies warrants cautious interpretation. Focusing on promising candidates, this meta-analysis explored the potential of salivary protein biomarkers for diagnosing OSCC. Notably, MMP9 and CYFRA21-1 demonstrated good sensitivity, suggesting their strong potential for further development as noninvasive diagnostic tools.
鉴定和评估唾液蛋白生物标志物对口腔鳞状细胞癌(OSCC)的无创诊断可显著提高早期发现,指导及时干预,最终提高患者的生存和生活质量。我们对PubMed、谷歌Scholar和EMBASE数据库进行了全面的检索,以确定评估唾液蛋白生物标志物筛查OSCC潜力的研究。为了评估研究的有效性,两位审稿人独立提取了敏感性、特异性、阳性和阴性似然比(PLR和NLR)和诊断优势比(DOR)的数据。由于研究之间的预期差异,我们使用随机效应模型来组合提取的数据。荟萃分析纳入了28项研究,包括3507名OSCC患者和3501名对照受试者,评估了37种唾液蛋白生物标志物。所有生物标志物的汇总分析显示,敏感性为0.71(95 % CI 0.690-0.720),特异性为0.69(95 % CI 0.68-0.71), PLR为3.04(95 % CI 2.56-3.60), NLR为0.37(95 % CI 0.33-0.43), DOR为11.7(95 % CI 8.02-15.29)。进一步分析比较了五种特异性生物标志物:白细胞介素-1β (IL-1β)、肿瘤坏死因子-α (TNF-α)、白细胞介素-8 (IL-8)、基质金属蛋白酶-9 (MMP9)和细胞角蛋白19片段21-1 (CYFRA21-1)。值得注意的是,MMP9和CYFRA21-1的敏感性分别为1.00和0.81,特异性分别为0.58和0.91,高曲线下面积(AUC)值分别为0.9932和0.9447。尽管结果令人鼓舞,但研究的异质性值得谨慎解释。本荟萃分析着眼于有希望的候选患者,探讨了唾液蛋白生物标志物诊断OSCC的潜力。值得注意的是,MMP9和CYFRA21-1表现出良好的敏感性,表明它们作为无创诊断工具的进一步发展潜力巨大。
{"title":"Salivary protein biomarkers for the diagnosis of oral squamous cell carcinoma: a systematic review and meta-analysis.","authors":"Jayesh Beladiya, Dhruvi Mehta, Yashi Patel, Sandip Patel, Dharmistha Parmar, Sandip Dholakia, Devang Sheth, B Mahalakshmi, Chirag A Patel, Sai H S Boddu","doi":"10.1515/dx-2025-0058","DOIUrl":"https://doi.org/10.1515/dx-2025-0058","url":null,"abstract":"<p><p>Identifying and assessing salivary protein biomarkers for the noninvasive diagnosis of oral squamous cell carcinoma (OSCC) could significantly enhance early detection, guide timely intervention, and ultimately improve patient survival and quality of life. A comprehensive search of PubMed, Google Scholar, and EMBASE databases was conducted to identify studies that assessed the potential of salivary protein biomarkers for screening OSCC. To assess the validity of the studies, two reviewers independently extracted data on sensitivity, specificity, positive and negative likelihood ratios (PLR and NLR), and diagnostic odds ratios (DOR). Owing to the expected variation between studies, a random effects model was used to combine the extracted data. The meta-analysis included 28 studies including 3,507 patients with OSCC and 3,501 control subjects that evaluated 37 salivary protein biomarkers. Pooled analysis across all biomarkers revealed a sensitivity of 0.71 (95 % CI 0.690-0.720), specificity of 0.69 (95 % CI 0.68-0.71), PLR of 3.04 (95 % CI 2.56-3.60), NLR of 0.37 (95 % CI 0.33-0.43), and DOR of 11.7 (95 % CI 8.02-15.29). Further analysis compared five specific biomarkers: interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-8), matrix metalloproteinase-9 (MMP9), and cytokeratin 19 fragment 21-1 (CYFRA21-1). Notably, MMP9 and CYFRA21-1 demonstrated sensitivity of 1.00 and 0.81, respectively, with specificities of 0.58 and 0.91, respectively, and high area under the curve (AUC) values of 0.9932 and 0.9447, respectively. Despite promising results, heterogeneity across studies warrants cautious interpretation. Focusing on promising candidates, this meta-analysis explored the potential of salivary protein biomarkers for diagnosing OSCC. Notably, MMP9 and CYFRA21-1 demonstrated good sensitivity, suggesting their strong potential for further development as noninvasive diagnostic tools.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145367842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Margaret E Tashjian, Jessica Parker, Rebecca G Edwards Mayhew, Halden F Scott, Joseph A Grubenhoff
Objectives: Missed opportunities for diagnostic excellence are common and can lead to delayed diagnoses and initiation of treatment. Medical teams incorporate many elements into the diagnostic process, including patient factors, medical knowledge, data gathering, care environment, subspecialized personnel, and hospital processes. A case-based discussion describes how search satisfying - the tendency to stop searching once something has been found - and authority gradients can lead to delays in diagnosis.
Case presentation: A 2-year-old girl repeatedly presents to the emergency department with vomiting and periorbital swelling progressing to esotropia, initially found to have normal short-sequence MR brain imaging. After nonspecific labs and reassuring initial imaging, ophthalmologic consultation obtained during the child's third emergency department visit proposed plausible diagnoses of benign post-viral esotropia or decompensated esotropia. When her exam worsened at ophthalmology clinic follow up, she was referred back to the emergency department for complete MR brain and orbit imaging leading to a diagnosis of bilateral orbital myositis.
Conclusions: Examining the diagnostic process through integrated commentary, this case emphasizes the importance of recognizing limitations of short-sequencing advanced imaging and continuing the diagnostic pursuit in collaboration with consultants. A fishbone diagram visually demonstrates the factors that lead to a missed opportunity for diagnostic excellence. The case concludes with clinical teaching points in addition to a pitfall, myth, and pearl specific to search satisfying and authority gradients.
{"title":"Lessons in clinical reasoning - pitfalls, myths, and pearls: how search satisfying can keep eyes crossed.","authors":"Margaret E Tashjian, Jessica Parker, Rebecca G Edwards Mayhew, Halden F Scott, Joseph A Grubenhoff","doi":"10.1515/dx-2025-0057","DOIUrl":"https://doi.org/10.1515/dx-2025-0057","url":null,"abstract":"<p><strong>Objectives: </strong>Missed opportunities for diagnostic excellence are common and can lead to delayed diagnoses and initiation of treatment. Medical teams incorporate many elements into the diagnostic process, including patient factors, medical knowledge, data gathering, care environment, subspecialized personnel, and hospital processes. A case-based discussion describes how search satisfying - the tendency to stop searching once something has been found - and authority gradients can lead to delays in diagnosis.</p><p><strong>Case presentation: </strong>A 2-year-old girl repeatedly presents to the emergency department with vomiting and periorbital swelling progressing to esotropia, initially found to have normal short-sequence MR brain imaging. After nonspecific labs and reassuring initial imaging, ophthalmologic consultation obtained during the child's third emergency department visit proposed plausible diagnoses of benign post-viral esotropia or decompensated esotropia. When her exam worsened at ophthalmology clinic follow up, she was referred back to the emergency department for complete MR brain and orbit imaging leading to a diagnosis of bilateral orbital myositis.</p><p><strong>Conclusions: </strong>Examining the diagnostic process through integrated commentary, this case emphasizes the importance of recognizing limitations of short-sequencing advanced imaging and continuing the diagnostic pursuit in collaboration with consultants. A fishbone diagram visually demonstrates the factors that lead to a missed opportunity for diagnostic excellence. The case concludes with clinical teaching points in addition to a pitfall, myth, and pearl specific to search satisfying and authority gradients.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145336629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rick Roos, Laura Zwaan, Myrthe Maranus, Iwan A Meynaar, Vanessa J Valk, Cees van Nieuwkoop, Gert-Jan Kamps, Hardeep Singh, Maarten O van Aken
Objectives: The focus on improving patient safety has mainly been by learning from errors and near misses (Safety-I). We applied a novel Safety-II approach to identify and learn from practice variations in the diagnostic process in the emergency department (ED), and subsequently design and implement practice changes.
Methods: In this single-center study, we used action research (cycles of micro-experiments to study and improve processes with active stakeholder involvement) in the diagnostic process. We used three subsequent observation cycles of the following six steps: observations, gathering of follow-up data, analyses, a co-creation session with involved stakeholders, sharing of best practices, and updating the observation form. The observations and analyses focused on identifying practice variation in everyday practice rather than on what went right or wrong. During co-creation sessions, stakeholders discussed whether practice variations were reflective of possible improvements in the diagnostic process. Promising best practices were identified, and subsequently implemented as practice changes aiming to improve the diagnostic process. Implemented practice changes were evaluated in subsequent cycles.
Results: Forty diagnostic processes were observed. We identified practice variations that reflected the resilience and adaptability of clinicians, as well as variations revealing opportunities to improve the diagnostic process. Five identified best practices were implemented as practice changes: a template for the documentation of ED preannouncements, a document with relevant digital information resources for residents, face-to-face supervision by Internal Medicine consultants during office hours, blood sampling at triage, and adding lipase to the standard ED blood tests. These changes were well-received by stakeholders, also shown by an adoption-rate of 67-100 % of observed cases after implementation.
Conclusions: A Safety-II approach with action research and direct observations of the diagnostic process in the ED can be successfully applied to identify and learn from practice variation, and can lead to well-received practice changes.
{"title":"A Safety-II approach to learn from practice variation in the diagnostic process in the emergency department: an action research study.","authors":"Rick Roos, Laura Zwaan, Myrthe Maranus, Iwan A Meynaar, Vanessa J Valk, Cees van Nieuwkoop, Gert-Jan Kamps, Hardeep Singh, Maarten O van Aken","doi":"10.1515/dx-2025-0087","DOIUrl":"https://doi.org/10.1515/dx-2025-0087","url":null,"abstract":"<p><strong>Objectives: </strong>The focus on improving patient safety has mainly been by learning from errors and near misses (Safety-I). We applied a novel Safety-II approach to identify and learn from practice variations in the diagnostic process in the emergency department (ED), and subsequently design and implement practice changes.</p><p><strong>Methods: </strong>In this single-center study, we used action research (cycles of micro-experiments to study and improve processes with active stakeholder involvement) in the diagnostic process. We used three subsequent observation cycles of the following six steps: observations, gathering of follow-up data, analyses, a co-creation session with involved stakeholders, sharing of best practices, and updating the observation form. The observations and analyses focused on identifying practice variation in everyday practice rather than on what went right or wrong. During co-creation sessions, stakeholders discussed whether practice variations were reflective of possible improvements in the diagnostic process. Promising best practices were identified, and subsequently implemented as practice changes aiming to improve the diagnostic process. Implemented practice changes were evaluated in subsequent cycles.</p><p><strong>Results: </strong>Forty diagnostic processes were observed. We identified practice variations that reflected the resilience and adaptability of clinicians, as well as variations revealing opportunities to improve the diagnostic process. Five identified best practices were implemented as practice changes: a template for the documentation of ED preannouncements, a document with relevant digital information resources for residents, face-to-face supervision by Internal Medicine consultants during office hours, blood sampling at triage, and adding lipase to the standard ED blood tests. These changes were well-received by stakeholders, also shown by an adoption-rate of 67-100 % of observed cases after implementation.</p><p><strong>Conclusions: </strong>A Safety-II approach with action research and direct observations of the diagnostic process in the ED can be successfully applied to identify and learn from practice variation, and can lead to well-received practice changes.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145279106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-13eCollection Date: 2025-11-01DOI: 10.1515/dx-2025-0132
Andrew P J Olson, Joseph J Rencic, Thilan P Wijesekera
In the decade since the National Academies of Sciences, Engineering, and Medicine (NASEM) report Improving Diagnosis in Health Care, substantial progress has been made in understanding and teaching diagnostic reasoning. This manuscript reviews key advancements in the science and theory of clinical reasoning, including the shift from exclusive focus on individual cognitive models to those that embrace context and team-based approaches. Recent innovations in diagnosis education, such as development of formal competencies, use of structured reflection, and approaches to assessment are discussed. Despite these gains, challenges remain in translating theory into practice, particularly in curricular innovation and implementation, faculty development, and assessment. The emergence of generative artificial intelligence presents both opportunities and imperatives for reimagining diagnosis education. The authors call for sustained efforts to embed diagnostic excellence across health professions education, emphasizing interprofessional collaboration, patient engagement, and system-level reform to reduce diagnostic error and improve outcomes.
{"title":"Diagnosis education: a decade of progress, with more needed.","authors":"Andrew P J Olson, Joseph J Rencic, Thilan P Wijesekera","doi":"10.1515/dx-2025-0132","DOIUrl":"10.1515/dx-2025-0132","url":null,"abstract":"<p><p>In the decade since the National Academies of Sciences, Engineering, and Medicine (NASEM) report <i>Improving Diagnosis in Health Care</i>, substantial progress has been made in understanding and teaching diagnostic reasoning. This manuscript reviews key advancements in the science and theory of clinical reasoning, including the shift from exclusive focus on individual cognitive models to those that embrace context and team-based approaches. Recent innovations in diagnosis education, such as development of formal competencies, use of structured reflection, and approaches to assessment are discussed. Despite these gains, challenges remain in translating theory into practice, particularly in curricular innovation and implementation, faculty development, and assessment. The emergence of generative artificial intelligence presents both opportunities and imperatives for reimagining diagnosis education. The authors call for sustained efforts to embed diagnostic excellence across health professions education, emphasizing interprofessional collaboration, patient engagement, and system-level reform to reduce diagnostic error and improve outcomes.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"588-595"},"PeriodicalIF":2.0,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145274115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dana M Al Baali, Mahmoud M Ajoub, Issa S Al Qarshoubi, Babikir M Ismail, Abdullah A Al Rawahi, Fabrizio Panaro, Abdulateef S Al Sulaimani, Abdullah Y Al Farai
Objectives: Hepatic sclerosing hemangioma (SH) is a rare benign liver lesion that poses a significant diagnostic challenge due to its ability to mimic malignant hepatic tumors on imaging.
Case presentation: We report the case of a 67-year-old woman with diabetes, hypertension, and chronic kidney disease who presented with incidental liver lesions discovered during the workup of elevated alkaline phosphatase. Cross-sectional imaging, including MRI and PET-FDG, revealed multiple atypical hypodense hepatic lesions with perihilar biliary obstruction, initially raising concern for cholangiocarcinoma. Multiple tissue biopsies including Spyglass-guided and percutaneous attempts were non-diagnostic, and the clinical suspicion of malignancy persisted. Diagnostic laparoscopy and targeted incisional biopsy ultimately confirmed the diagnosis of sclerosing hemangioma. The patient underwent laparoscopic wedge resection and has remained well on follow-up for more than two years.
Conclusions: This case highlights the importance of maintaining a broad differential diagnosis in the evaluation of atypical hepatic lesions, the limitations of radiological findings, and the value of a stepwise multidisciplinary approach in avoiding unnecessary major resections. A focused review of the literature supports the rarity of this entity and emphasizes the need for tissue diagnosis in ambiguous cases.
{"title":"Multiple hepatic sclerosing hemangiomas mimicking malignant lesions, a diagnostic dilemma: case report and literature review.","authors":"Dana M Al Baali, Mahmoud M Ajoub, Issa S Al Qarshoubi, Babikir M Ismail, Abdullah A Al Rawahi, Fabrizio Panaro, Abdulateef S Al Sulaimani, Abdullah Y Al Farai","doi":"10.1515/dx-2025-0078","DOIUrl":"https://doi.org/10.1515/dx-2025-0078","url":null,"abstract":"<p><strong>Objectives: </strong>Hepatic sclerosing hemangioma (SH) is a rare benign liver lesion that poses a significant diagnostic challenge due to its ability to mimic malignant hepatic tumors on imaging.</p><p><strong>Case presentation: </strong>We report the case of a 67-year-old woman with diabetes, hypertension, and chronic kidney disease who presented with incidental liver lesions discovered during the workup of elevated alkaline phosphatase. Cross-sectional imaging, including MRI and PET-FDG, revealed multiple atypical hypodense hepatic lesions with perihilar biliary obstruction, initially raising concern for cholangiocarcinoma. Multiple tissue biopsies including Spyglass-guided and percutaneous attempts were non-diagnostic, and the clinical suspicion of malignancy persisted. Diagnostic laparoscopy and targeted incisional biopsy ultimately confirmed the diagnosis of sclerosing hemangioma. The patient underwent laparoscopic wedge resection and has remained well on follow-up for more than two years.</p><p><strong>Conclusions: </strong>This case highlights the importance of maintaining a broad differential diagnosis in the evaluation of atypical hepatic lesions, the limitations of radiological findings, and the value of a stepwise multidisciplinary approach in avoiding unnecessary major resections. A focused review of the literature supports the rarity of this entity and emphasizes the need for tissue diagnosis in ambiguous cases.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145231849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Clinical reasoning skills are required for safe care, yet they are not consistently taught to advanced practice providers (APPs). In hospital medicine, where APPs work semi-independently, gaps in clinical reasoning can increase the likelihood of error. To address this, we developed a module that uses diagnostic root cause analysis (RCA) to teach clinical reasoning skills to hospital medicine APP fellows.
Methods: The curriculum was delivered from July 2021 to March 2025. Fellows selected real-world diagnostic errors encountered during clinical rotations, created cognitive fishbone diagrams, and presented their analysis in small-group.
Results: Twenty-seven fellows completed the module and pre-post assessment surveys. Statistically significant improvements were observed across all six domains of knowledge and confidence related to identifying error contributors, analyzing cases, and setting goals. Free-text responses highlighted the module's emotional safety, peer learning value, and normalization of diagnostic reflection. Two learners published their projects as academic posters, and one graduate now co-facilitates the sessions.
Conclusions: This module offers a scalable, time-efficient approach to clinical reasoning education that is adaptable across learner levels and specialties. Its peer-led design fosters psychological safety, reflective practice, and creates a natural pathway for APPs to engage in microscholarship - addressing a critical gap in both education and academic inclusion.
{"title":"Rooted in reasoning: a clinical reasoning curriculum using diagnostic RCAs.","authors":"David Klimpl, Stacey Staudinger","doi":"10.1515/dx-2025-0089","DOIUrl":"https://doi.org/10.1515/dx-2025-0089","url":null,"abstract":"<p><strong>Objectives: </strong>Clinical reasoning skills are required for safe care, yet they are not consistently taught to advanced practice providers (APPs). In hospital medicine, where APPs work semi-independently, gaps in clinical reasoning can increase the likelihood of error. To address this, we developed a module that uses diagnostic root cause analysis (RCA) to teach clinical reasoning skills to hospital medicine APP fellows.</p><p><strong>Methods: </strong>The curriculum was delivered from July 2021 to March 2025. Fellows selected real-world diagnostic errors encountered during clinical rotations, created cognitive fishbone diagrams, and presented their analysis in small-group.</p><p><strong>Results: </strong>Twenty-seven fellows completed the module and pre-post assessment surveys. Statistically significant improvements were observed across all six domains of knowledge and confidence related to identifying error contributors, analyzing cases, and setting goals. Free-text responses highlighted the module's emotional safety, peer learning value, and normalization of diagnostic reflection. Two learners published their projects as academic posters, and one graduate now co-facilitates the sessions.</p><p><strong>Conclusions: </strong>This module offers a scalable, time-efficient approach to clinical reasoning education that is adaptable across learner levels and specialties. Its peer-led design fosters psychological safety, reflective practice, and creates a natural pathway for APPs to engage in microscholarship - addressing a critical gap in both education and academic inclusion.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145231838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-07eCollection Date: 2025-11-01DOI: 10.1515/dx-2025-0124
Sundas Khan, Andrea Bradford, Christina L Cifra, Hardeep Singh
Since the National Academies of Sciences, Engineering, and Medicine (NASEM) report Improving Diagnosis in Health Care, various research efforts have accelerated progress to understand and improve diagnostic safety. In this opinion piece, we summarize two decades of progress in methods for identifying and learning from diagnostic errors and provide recommendations for future research. Multiple methods have been used to quantify diagnostic errors in various clinical settings, thereby facilitating a deeper understanding of the nature and magnitude of the problem and enabling studies of contributing factors. However, the use of standardized definitions of a diagnostic error and/or diagnostic safety event, a shared mental model for measurement, and more universal application of tools to measure these events across the research enterprise are still needed. We highlight progress in selected research methods and applications, such as co-development with patients, inclusion of multidisciplinary perspectives (such as those from informatics, human factors, and social and cognitive sciences), and the use of sociotechnical approaches. Specific areas where research should be prioritized include the application of cognitive science to the real-world study of diagnostic errors, understanding the costs associated with diagnostic safety, developing and implementing interventions related to patient engagement, evaluating and integrating artificial intelligence, and implementing system-related interventions to improve diagnosis. To promote broad-scale improvement in diagnostic safety over the next decade, we provide several actionable steps and recommendations for various audiences, including researchers, research funders, safety professionals, and policymakers, involved in research and implementation activities for reducing preventable diagnostic harm.
{"title":"Two decades of diagnostic safety research: advances, challenges, and next steps.","authors":"Sundas Khan, Andrea Bradford, Christina L Cifra, Hardeep Singh","doi":"10.1515/dx-2025-0124","DOIUrl":"10.1515/dx-2025-0124","url":null,"abstract":"<p><p>Since the National Academies of Sciences, Engineering, and Medicine (NASEM) report <i>Improving Diagnosis in Health Care</i>, various research efforts have accelerated progress to understand and improve diagnostic safety. In this opinion piece, we summarize two decades of progress in methods for identifying and learning from diagnostic errors and provide recommendations for future research. Multiple methods have been used to quantify diagnostic errors in various clinical settings, thereby facilitating a deeper understanding of the nature and magnitude of the problem and enabling studies of contributing factors. However, the use of standardized definitions of a diagnostic error and/or diagnostic safety event, a shared mental model for measurement, and more universal application of tools to measure these events across the research enterprise are still needed. We highlight progress in selected research methods and applications, such as co-development with patients, inclusion of multidisciplinary perspectives (such as those from informatics, human factors, and social and cognitive sciences), and the use of sociotechnical approaches. Specific areas where research should be prioritized include the application of cognitive science to the real-world study of diagnostic errors, understanding the costs associated with diagnostic safety, developing and implementing interventions related to patient engagement, evaluating and integrating artificial intelligence, and implementing system-related interventions to improve diagnosis. To promote broad-scale improvement in diagnostic safety over the next decade, we provide several actionable steps and recommendations for various audiences, including researchers, research funders, safety professionals, and policymakers, involved in research and implementation activities for reducing preventable diagnostic harm.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":"12 4","pages":"549-556"},"PeriodicalIF":2.0,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-03eCollection Date: 2025-11-01DOI: 10.1515/dx-2025-0131
Mark L Graber, Edward P Hoffer, Hardeep Singh
{"title":"Foreword: addressing diagnostic error: the first 10 years.","authors":"Mark L Graber, Edward P Hoffer, Hardeep Singh","doi":"10.1515/dx-2025-0131","DOIUrl":"10.1515/dx-2025-0131","url":null,"abstract":"","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":"12 4","pages":"491-492"},"PeriodicalIF":2.0,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Diagnostic errors in acute cholecystitis significantly impact patient safety. Misdiagnosis, including both false negatives and false positives, is common due to the complex nature of abdominal pain and the overlapping symptoms of various conditions. This scoping review examines the definition, prevalence, and contributing factors of diagnostic errors in acute cholecystitis, emphasizing the need for improved diagnostic processes.
Content: Employing the PRISMA-ScR framework, this review examined definitions and factors contributing to diagnostic errors in cholecystitis. It highlights the variability in diagnostic criteria, with many studies relying on clinical judgment rather than standardized guidelines such as the Tokyo Guidelines. False negative diagnoses are often due to hypoalbuminemia, inconspicuous imaging findings, and the clinical setting, whereas false positives often result from misinterpreted imaging findings and failure to differentiate from other conditions.
Summary: This review found that approximately 30 % of acute cholecystitis cases may be missed (false negative), and 20-36 % of cases initially diagnosed can be incorrect (false positive). Adherence to standardized guidelines and improved recognition of atypical presentations could reduce diagnostic errors.
Outlook: Future research should aim for large-scale studies with clear diagnostic criteria and detailed clinical data to enhance diagnostic accuracy and patient safety.
{"title":"Diagnostic errors in acute cholecystitis: a scoping review.","authors":"Taku Harada, Taiju Miyagami, Yukinori Harada, Taro Shimizu","doi":"10.1515/dx-2025-0061","DOIUrl":"https://doi.org/10.1515/dx-2025-0061","url":null,"abstract":"<p><strong>Introduction: </strong>Diagnostic errors in acute cholecystitis significantly impact patient safety. Misdiagnosis, including both false negatives and false positives, is common due to the complex nature of abdominal pain and the overlapping symptoms of various conditions. This scoping review examines the definition, prevalence, and contributing factors of diagnostic errors in acute cholecystitis, emphasizing the need for improved diagnostic processes.</p><p><strong>Content: </strong>Employing the PRISMA-ScR framework, this review examined definitions and factors contributing to diagnostic errors in cholecystitis. It highlights the variability in diagnostic criteria, with many studies relying on clinical judgment rather than standardized guidelines such as the Tokyo Guidelines. False negative diagnoses are often due to hypoalbuminemia, inconspicuous imaging findings, and the clinical setting, whereas false positives often result from misinterpreted imaging findings and failure to differentiate from other conditions.</p><p><strong>Summary: </strong>This review found that approximately 30 % of acute cholecystitis cases may be missed (false negative), and 20-36 % of cases initially diagnosed can be incorrect (false positive). Adherence to standardized guidelines and improved recognition of atypical presentations could reduce diagnostic errors.</p><p><strong>Outlook: </strong>Future research should aim for large-scale studies with clear diagnostic criteria and detailed clinical data to enhance diagnostic accuracy and patient safety.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145291633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}